Clinical Diagnostics Technology & Disease Research News | 360Dx
WEBEmerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.
About Us - 360Dx
WEBGenomeWeb Crain Communications, Inc. 685 Third Avenue New York, NY 10017 T: 212-210-0100
Breaking News - 360Dx
WEBSep 27, 2024 — According to the government, Rashid Naqvi, a Houston-area resident, fraudulently sought $4.6 million from Medicare for COVID-19 test kits and obtained $2.0 million.
Diagnostic Technologies and Applications - 360Dx
WEBThe German molecular diagnostics and reagents firm said it has converted more than 80 percent of a planned total of 180 products to the new IVDR regulatory framework.
Coronavirus Test Tracker: Commercially Available COVID-19 ... - 360Dx
WEBAs labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV-2 coronavirus, 360Dx is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets.
coronavirus Diagnostics News | 360Dx
WEBBreaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.
Lumos Diagnostics Sets Stage for US Expansion With New …
WEB2 days ago — NEW YORK –With nearly $10 million in recent contracts and financing, and new distribution agreements in place, Australian infectious disease company Lumos Diagnostics hopes to obtain CLIA waiver for its FebriDx rapid host-response test next year to catalyze its US expansion.
Exact Sciences Nabs FDA Approval for Cologuard Plus Assay
WEB2 days ago — NEW YORK – Exact Sciences announced on Friday that its next-generation Cologuard Plus test has received approval from the US Food and Drug Administration. The multitarget stool DNA test was approved for use in adults ages 45 and older who are at average risk for colorectal cancer. The approval was ...
COVID-19 Diagnostics News - 360Dx
WEBJul 24, 2024 — News and reporting on COVID-19 from 360Dx Diagnostics. Timothy Peoples and Willie Ann Cleveland have pleaded not guilty to charges that they received and paid kickbacks for genetic and COVID-19 testing.
Harvard Researchers Develop AI-Based Model for Cancer Dx, …
WEBSep 6, 2024 — NEW YORK – Researchers from Harvard Medical School have developed a new artificial intelligence-based model for systematically diagnosing multiple cancer types and predicting patients' prognoses from digital pathology images. Described in a paper published this week in Nature, the Clinical ...